Why PathAI exists
PathAI interprets pathology images using AI and machine learning to support diagnosis, prognosis, and prediction of treatment response. Its analysis can act as a proxy when tissue is no longer available for testing, for example predicting a gene mutation from an H&E slide. Patients weighing their options gain an additional layer of evidence behind the decision.
Industry adoption · States that 90% of the top 15 biopharma companies use its technologyPathologist network · 450+ board-certified pathologistsLabcorp collaboration · Nationwide deployment of an FDA-cleared digital pathology platformRoche · Definitive merger agreement announced
Prefer the source? PathAI's own site has more.
